MEDBOX | Category Trachoma

Trachoma

Advanced search

Create your MEDBOX

Trachoma

Advanced search

Create your MEDBOX

Go back

OUR RECOMMENDATIONS

NEW

NEW

Chronic Care for Neglected Infectious Diseases: Leprosy/Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease (2021)

Chronic Care for Neglected Infectious Diseases: Leprosy/ Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease (2021)

Safety in administering medicines for neglected tropical diseases (2021)

LIST OPTIONS

FILTER BY LANGUAGE

FILTER BY COUNTRY

SORT BY

RESULTS/PAGE

LIST TYPE

7 records

	Chronic Care for Neglected Infectious Diseases: Leprosy/ Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease PAHO PAHO, WHO (2021) CC View PDF(42) Download (21) Add to my MEDBOX In 2016, PAHO's Directing Council, through Resolution CD55.R9, approved the “Plan of Action for Elimination of Neglected Infectious Diseases (NID) and Post-Elimination Actions, 2016-2022.” This Resolution urges Member States to implement a set of interventions to reduce the burden of disease by NID in the Americas by 2022, including “…support promotion of treatment, rehabilitation, and related support services through an approach focused on integrated morbidity management and disability prevention for individuals and families afflicted by those neglected infectious diseases that cause disability and generate stigma.” NIDs can have devastating chronic sequelae for patients, such as disability, visible change or loss in body structure, loss of tissue, and impairment of proper tissue and organ function, among others. All of these can in turn lead to unjustified discrimination, stigmatization, mental health problems, and partial or total incapacity to work, perpetuating the vicious cycle of neglected diseases as both a consequence and a cause of poverty. Patients with chronic conditions caused by NIDs require proper health care in order to prevent further damage and improve their living and social conditions. This should be provided at the primary health care level, as patients suffering from NIDs are often unable to travel to or afford to pay for specialized care services. Care for patients suffering from chronic morbidity caused by NID should be integrated into care for other chronic conditions caused by non-communicable diseases. This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be used mainly by health care workers at the primary health care level, but health workers at more complex and specialized levels may also find it useful Tags: Guidelines, care and prevention, Chagas, Lymphatic filariasis, Leprosy, Trachoma, Source: https://iris.paho.org/handle/10665.2/533
	Chronic Care for Neglected Infectious Diseases: Leprosy/Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease Pan American Health Organisation PAHO (2021) C_WHO View PDF(128) Download (145) Add to my MEDBOX This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be used mainly by health care workers at the primary health care level, but health workers at more complex and specialized levels may also find it useful Tags: Leprosy, Lymphatic filariasis, Chagas, Trachoma, Neglected Tropical Diseases (NTDs), care, health-care workers, primary health care, Source: https://iris.paho.org/bitstream/handle/1
	Safety in administering medicines for neglected tropical diseases World Health Organization WHO (2021) C_WHO View PDF(152) Download (212) Add to my MEDBOX This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjunction with the accompanying training modules, which provide practical instruction, and the aide-mémoires. Versions of the aide-mémoires and training modules are available respectively for both (i) programme managers and district-level health officials and (ii) community drug distributors and community health worker Tags: NTD, neglected tropical diseases, Essential Medicine, job aid, Training, practical instructions, programme managers, health professionals, chemotherapy, mass drug, Community Health Worker (CHW), Source: https://apps.who.int/iris/rest/bitstream
	Design and validation of a trachomatous trichiasis - only survey World Health Organization (WHO), Strategic and Technical Advisory Group for Neglected Tropical Diseases, Working Group on Monitoring and Evaluation (2017) C_WHO View PDF(638) Download (303) Add to my MEDBOX The World Health Organization (WHO) endorses the use of population-based prevalence surveys for estimating the prevalence of trachoma. In general, the prevalence of TF in children aged 1–9 years and the prevalence of TT in adults aged ≥ 15 years are measured at the same time in any district being surveyed. This was the approach of the Global Trachoma Mapping Project, which undertook baseline surveys in > 1500 districts worldwide in order to provide the data required to start interventions where needed. The survey design recommended by WHO is a two-stage cluster random sample survey, which uses probability proportional to size sampling to select 20–30 villages, and random, systematic or quasi-random sampling to select 25–30 households in each of those villages. In most surveys, everyone aged ≥ 1 year living in selected households is examined Tags: trachomatous trichiasis (TT), prevalence surveys, Source: https://apps.who.int/iris/bitstream/hand
	Conception et validation d’une enquête sur le seul trichiasis trachomateux Organisation mondiale de la Santé (OMS), Groupe consultatif stratégique et technique sur les maladies tropicales négligées, Groupe de travail du contrôle et de l’évaluation (2017) C_WHO View PDF(519) Download (392) Add to my MEDBOX The World Health Organization (WHO) endorses the use of population-based prevalence surveys for estimating the prevalence of trachoma. In general, the prevalence of TF in children aged 1–9 years and the prevalence of TT in adults aged ≥ 15 years are measured at the same time in any district being surveyed. This was the approach of the Global Trachoma Mapping Project, which undertook baseline surveys in > 1500 districts worldwide in order to provide the data required to start interventions where needed. The survey design recommended by WHO is a two-stage cluster random sample survey, which uses probability proportional to size sampling to select 20–30 villages, and random, systematic or quasi-random sampling to select 25–30 households in each of those villages. In most surveys, everyone aged ≥ 1 year living in selected households is examined Tags: trachomatous trichiasis (TT), prevalence surveys, Source: https://apps.who.int/iris/bitstream/hand
	Validation of elimination of trachoma as a public health problem World Health Organization (WHO) (2016) C_WHO View PDF(458) Download (285) Add to my MEDBOX Tags: Public health, elimination, Trachoma, trachomatous trichiasis (TT), Source: https://apps.who.int/iris/bitstream/hand
	Validation de l'élimination du trachome en tant que problème de santé publique Organisation mondiale de la Santé (OMS) (2016) C_WHO View PDF(440) Download (275) Add to my MEDBOX Tags: Public health, elimination, Trachoma, trachomatous trichiasis (TT), Source: https://apps.who.int/iris/bitstream/hand

7 records

7 records